Bio-Techne (NASDAQ:TECH) Rating Lowered to Neutral at Citigr

Citigroup lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a neutral rating in a research note issued to investors on Wednesday morning, MarketBeat.com reports. Citigroup currently has $85.00 price target on the biotechnology company’s stock. A number of other analysts have also commented on TECH. Stephens dropped their price target […]

Related Keywords

United States , Tokio , Tokyo , Japan , Texas , China , Canada , United Kingdom , California , Roeland Nusse , Robertw Baird , Tokio Marine Asset Management Co , Royal Bank , Principal Financial Group Inc , Deutsche Bank Aktiengesellschaft , Bio Techne Corporation , Bio Techne Company Profile , Scotiabank , California Public Employees Retirement System , Life Insurance Company Ltd , Citigroup , Free Report , Bank Aktiengesellschaft , Moderate Buy , Get Free Report , Director Roeland Nusse , Retirement System , Financial Group , Public Employees Retirement System , Marine Asset Management , Techne Corporation , Middle East , Greater China , Bio Techne Daily ,